The shareholders of Avanza Bank Holding AB (publ) are hereby given notice that the Extraordinary General Meeting of the company is convened to be held on Wednesday December 2, 2015 at 15.00 (CET), at the company’s premises on Regeringsgatan 103, Stockholm, Sweden. Right to participate in the General Meeting Shareholders who wish to participate in the General Meeting must be registered in the share register kept by Euroclear Sweden AB by Thursday, November 26, 2015, and notify of their participation in the General Meeting via e-mail to bolag@avanza.se or telephone number +46 (0)8-562 250 02. The notification must be submitted to the company no later than Thursday, November 26, 2015. The notification must state the shareholder’s name, personal ID or business registration number, e-mail address or daytime telephone number as well as the number of shares and, if applicable, the name of any representative or accompanying assistants. In order to have the right to participate in the General Meeting, shareholders whose shares are nominee-registered through a bank or other nominee, must temporarily re-register their shares in their own name with Euroclear Sweden AB. Shareholders who desire such re-registration must inform their nominee of this in good time before November 26, 2015, which is the last date for re -registration. Power of attorney form If shareholders intend to be represented by a proxy, such shareholders must send a power of attorney and other authorisation documents to Avanza Bank Holding AB, FAO: Bolagsjuridik, Box 1399, 111 93 Stockholm, Sweden. The power of attorney form is available on the company's web site www.avanza.se/ir and is sent free of charge to shareholders who request this, and provide their postal address or e -mail address. Proposal for agenda 1. Opening of the General Meeting 2. Appointment of a chairman for the meeting 3. Establishment and approval of the electoral register 4. Approval of the agenda 5. Appointment of one or two reviewers of the minutes 6. Examination of whether the meeting has been duly convened 7. Appointment of Board member 8. Closing of the General Meeting Proposals Appointment of a chairman for the meeting, point 2 The Board of Directors proposes that Sven Hagströmer be appointed chairman of the General Meeting. Appointment of Board member, point 7 The Nomination Committee proposes the new appointment of Sophia Bendz. Information on the proposed Board member is available on the company’s web site, www.avanza.se/ir. The proposal for the new Board member means that the Board of Directors of the company fulfils the regulations of the Swedish Code of Corporate Governance regarding independence. Release of documents The Nomination Committee’s complete proposal including explanatory statement is available at the company’s office, Regeringsgatan 103, 111 39 Stockholm, and on the company’s web site www.avanza.se/ir. The documents will be sent free of charge to shareholders who so request and provide their postal address. The documents are available. The documents will also be available at the General Meeting. Information on the number of shares and votes as well as holding of own shares The total number of shares and votes in the company at the time of issue of this notification was 29,344,088. All shares issued are ordinary shares. The company has no repurchased shares. Shareholders' right to request information The Board of Directors and the CEO shall, if any shareholder so requests and if, in the opinion of the Board, it may be done without causing harm to the company, provide information at the General Meeting regarding circumstances that may affect assessment of an item on the agenda. Stockholm, November 2015 The Board of Directors of Avanza Bank Holding AB (publ)
Notice of Extraordinary General Meeting The shareholders of
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Triumph Financial Sets Stage for Q4 Earnings and Insights
Triumph Financial Plans Fourth Quarter Earnings Release Triumph Financial, Inc. (Nasdaq: TFIN) recently announced its anticipation for the release of fourth quarter financial results. This event is scheduled to take place after the market closes on an upcoming Wednesday. Along with the financial report, the company will provide management commentary for stakeholders and...
Continue Reading
Monitoring ABA Therapy Progress: A Parent's Guide
The Nuts and Bolts of Progress Monitoring You've got a situation in Leominster where parents are trying to make sense of ABA therapy's impact on their kids. Rob Shapiro, a big name in the ABA world, breaks it all down in a HelloNation article. We're talking about precise data collection being the backbone of measuring progress in ABA therapy. This ain't no place for...
Continue Reading
Understanding Dowlais Group's Recent Market Activities
Public Disclosure Regarding Dowlais Group's Trading Activity FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code 1. KEY INFORMATION (a) Name of exempt principal trader: Investec Bank plc (b) Name of offeror/offeree in relation to whose r
Continue Reading
OFS Credit Company Reports Impressive Q4 Financials for 2024
OFS Credit Company Delivers Strong Q4 2024 Financial Results OFS Credit Company, Inc. (NASDAQ: OCCI), a notable investment firm focusing on collateralized loan obligation (CLO) equity and debt securities, has announced its financial performance for the fiscal quarter ending October 31, 2024. This report outlines the company’s significant financial growth and strategic...
Continue Reading
Breakthrough Data on HBI-8000 and Nivolumab for Melanoma
HBI-8000 and Nivolumab: A New Era in Melanoma Treatment Recent findings highlight the potential of HBI-8000 in combination with nivolumab, suggesting a transformative approach in the treatment of advanced melanoma. This promising combination will be discussed in detail at an upcoming prestigious annual meeting focused on advancements in immunotherapy. Innovative Solutions...
Continue Reading